{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for pantothenic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
NCT00484757: Not Applicable Interventional Unknown status Narcolepsy
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01625260: Phase 1/Phase 2 Interventional Unknown status Non-muscle Invasive Bladder Cancer
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Class:
PROTEIN
FERTIRELIN is an analog of luteinizing hormone releasing factor. The drug has been used since 1981 in Japan to treat various types of reproductive failure in cattle.
Status:
Investigational
Source:
INN:cantuzumab mertansine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Eledoisin is an endecapeptide tachykinin receptor ligand. Originally it was isolated from salivary glands of Mediterranean octopod, Eledone moschata. Eledoisin is a powerful vasodilator and hypotensive agent in most animal species.
Status:
Designated
Source:
FDA ORPHAN DRUG:782420
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
FDA ORPHAN DRUG:810621
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
FDA ORPHAN DRUG:841321
Source URL:
Class:
PROTEIN
